Auriga
Auriga USA is a research and trading platform that focuses on growth sectors within the Health Care and Technology verticals. We operate out of our main office in New York City, and also have satellite offices in Boston, San Francisco, Philadelphia, San Diego, and Washington D.C. This regional network helps us to keep abreast of key corporate developments, enhance client relationships, and provide more efficient product distribution to meet clients' investment needs. The firm is committed to providing our clients with critical information flow, investment ideas, and access to industry experts.
View Older Stories View More Recent Stories
-
Auriga maintains a 'Hold' on Linear Technology (LLTC); Quick Look Ahead of the Call - Results/Guidance A Light
-
Auriga Tweaks Estimates on Texas Instruments (TXN) Following Q1 Results Q2 Guidance
-
Notable Analyst Rating Changes 04/15: (FITB) (FE) (MPEL) Upgraded; (GOOG) (CSCO) (CBST) Downgraded
-
Auriga Downgrades Cisco (CSCO) to Hold
-
Notable Analyst Rating Changes 04/14: (PTEN) (FRX) (HOG) Upgraded; (AN) (INTC) (TXT) Downgraded
-
Auriga Reiterates a 'Buy' on Daqo New Energy (DQ); Mr. Toad's Wild Ride
-
Auriga Assumes Coverage on Broadcom (BRCM) at Buy; Bullish on Connectivity/Ethernet Growth and Opex Discipline
-
Notable Analyst Rating Changes 04/13: (GTXI) (ALTR) (IRBT) Upgraded; (SUN) (MT) (LEDS) Downgraded
-
Auriga Maintains a 'Buy' on JA Solar Holdings (JASO); Silver Weighs on Costs
-
Auriga Assumes Coverage on Xilinx (XLNX) at Buy; Near-Term Risk, but Longer-Term Prospects Remain Attractive
-
Auriga Assumes Coverage and Upgrades Altera (ALTR) to Buy; Expecting Growth to Resume in 2H11
-
Auriga Maintains a 'Sell' on STR Holdings (STRI); Losing SunPower
-
Auriga Maintains a 'Buy' on Yingli Green Energy (YGE); Too Precious
-
Auriga Downgrades Heartware Intl (HTWR) to Hold; HVAD's INR Range Could Create Marketing Challenges
-
Auriga Maintains a 'Buy' on Power-One (PWER); Espresso Needed
-
Notable Analyst Rating Changes 04/07: (HERO) (ELN) (CRM) Upgraded; (MDRX) (CNL) (SSW) Downgraded
-
Auriga Downgrades Allscripts-Misys Healthcare (MDRX) to Hold
-
Auriga Reiterates a 'Buy' on Life Technologies (LIFE); Adjusting Estimates to Reflect Japan Impact
-
Auriga Reiterates a 'Buy' on Juniper Networks (JNPR); New Products Gaining Momentum; Secular Trends Remain Favorable
-
Auriga Maintains a 'Buy' on Thermo Fisher Scientific (TMO); Close of Dionex Acquisition Likely to Occur In May; Closes Two Divestitures
-
Auriga Maintains a 'Sell' on Texas Instruments (TXN); Cheap Money = Easily Accretive Deal
-
Auriga Maintains a 'Hold' on Maxim Integrated Products (MXIM); Growth Concerns Offset by Positive Japan Impact Plus M&A
-
Auriga Upgrades Linear Technology (LLTC) to Hold
-
Auriga Upgrades Analog Devices (ADI) to Hold
-
Auriga Reiterates a 'Buy' on Spreadtrum Communications (SPRD); 2Q11 Now Seems To Be Okay
-
Auriga Downgrades STR Holdings (STRI) to Sell; Where's the Units?
-
Auriga Upgrades NetLogic (NETL) to Buy
-
Auriga Upgrades Cavium Networks (CAVM) to Buy
-
Auriga on Renewable Technologies: Beyond Italy, Part 2
-
Auriga Reiterates a 'Buy' on MedAssets (MDAS); Tweaking Model While We Find Current Price Compelling
-
Auriga Reiterates a 'Buy' on Daqo New Energy (DQ); Expanding As Expected
-
Auriga Upgrades Illumina (ILMN) to Buy; Pullback Creates Opportunity to Own NGS Leader
-
Auriga Maintains a 'Hold' on Applied Materials (AMAT); Analyst Day: Upbeat Tone with Execution & Share Gains Highlighted
-
Auriga Reiterates a 'Sell' on Cree (CREE); Lowered Guidance May Only Be Tip Of Iceberg
-
Auriga Reiterates a 'Hold' on First Solar (FSLR); Zero French Expectations
-
Auriga Maintains a 'Buy' on Micron Technology (MU); No Surprises - Risk/Reward Remains Skewed to the Upside
-
Auriga Lowers Numbers on Hanwha SolarOne (HSOL); Lacking Excitement
-
Auriga Maintains a 'Buy' on Xilinx (XLNX); Analyst Day Increases Our Conviction in 28nm Potential
-
Japan Issues Should Temporarily Support Poly Prices, Auriga's Bachman Says; Daqo (DQ), ReneSola (SOL) Best Positioned To Benefit
-
Auriga Upgrades Cerner (CERN) to Buy
-
Auriga Maintains a 'Buy' on Auriga (UTSI); The Cash Remains Our Focus
-
Auriga Maintains a 'Buy' on Canadian Solar (CSIQ); Still Losing the Cost Battle
-
Auriga Maintains a 'Hold' on STR Holdings (STRI); Successfully Bailing the Boat
-
Auriga Upgrades Affymax, Inc. (AFFY) to Buy, Raises Price Target By 50%
-
Auriga Prefers Xilinx's (XLNX) Over Altera (ALTR) on Valuation and Potential Operating Leverage
-
Auriga Lowers Price Target on Sequenom (SQNM) But Keeps Buy Ahead of Coming "Data Storm"
-
Auriga Reiterates a 'Buy' on Daqo New Energy (DQ); Poly Steals the Show
-
Auriga Reiterates a 'Buy' on Suntech Power (STP); Almost Squeaky Clean
-
Auriga Tweaks Estimates on Intel (INTC) Following Acquisition's of McAfee and Infineon (IFX)
-
Auriga Still Remains Skeptic on NVIDIA (NVDA) Prior The Analyst Conference
